- $409.81m
- $252.30m
- $41.29m
- 56
- 24
- 66
- 47
REG - MaxCyte, Inc. MaxCyte, Inc. - MXCR - TR-1: Notification of major holdings
AnnouncementREG - MaxCyte, Inc. MaxCyte, Inc. - MXCR - Total Voting Rights
AnnouncementREG - MaxCyte, Inc. MaxCyte, Inc. - MXCR - Exercise of options and PDMR dealing
AnnouncementREG - MaxCyte, Inc. MaxCyte, Inc. - MXCR - TR-1
AnnouncementREG - MaxCyte, Inc. MaxCyte, Inc. - MXCR - TR-1: Notification of major holdings
AnnouncementREG - MaxCyte, Inc. MaxCyte, Inc. - MXCR - TR-1: Notification of Major Holdings
AnnouncementREG - MaxCyte, Inc. MaxCyte, Inc. - MXCR - Filing of Form 10-Q
AnnouncementREG - MaxCyte, Inc. MaxCyte, Inc. - MXCR - Second Quarter and Half-Year Results
AnnouncementREG - MaxCyte, Inc. MaxCyte, Inc. - MXCR - TR-1: Notification of major holdings
AnnouncementREG - MaxCyte, Inc. MaxCyte, Inc. - MXCR - Total Voting Rights and Block Listing Return
AnnouncementREG - MaxCyte, Inc. MaxCyte, Inc. - MXCR - Strategic Platform License with Prime Medicine
AnnouncementREG - MaxCyte, Inc. MaxCyte, Inc. - MXCR - Exercise of options and PDMR dealing
AnnouncementREG - MaxCyte, Inc. MaxCyte, Inc. - MXCR - TR-1: Notification of major holdings
AnnouncementREG - MaxCyte, Inc. MaxCyte, Inc. - MXCR - TR-1: Notification of major holdings
AnnouncementREG - MaxCyte, Inc. MaxCyte, Inc. - MXCR - TR-1: Notification of major holdings
AnnouncementREG - MaxCyte, Inc. MaxCyte, Inc. - MXCR - Notice of Second Quarter 2023 Financial Results
AnnouncementREG - MaxCyte, Inc. MaxCyte, Inc. - MXCR - TR-1: Notification of major holdings
AnnouncementREG - MaxCyte, Inc. MaxCyte, Inc. - MXCR - Signing of Strategic Platform License
AnnouncementREG - MaxCyte, Inc. MaxCyte, Inc. - MXCR - TR-1: Notification of major holdings
Announcement